We are live on ! Find out more
GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Delisted

GWPH was delisted on the 4th of May, 2021.

Back to rankings

68 hedge funds and large institutions have $446M invested in GW Pharmaceuticals Plc American Depositary Shares in 2014 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 7

175% more capital invested

Capital invested by funds: $162M → $446M (+$284M)

162% more funds holding

Funds holding: 26 → 68 (+42)

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

4% more call options, than puts

Call options by funds: $968K | Put options by funds: $927K

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
68
Holders Change
+42
Holders Change %
+161.54%
% of All Funds
1.96%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
49
Increased
8
Reduced
7
Closed
7
Calls
$968K
Puts
$927K
Net Calls
+$41K
Net Calls Change
+$41K

Top Buyers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
+$48.1M
2
Franklin Resources
Franklin Resources
California
+$28M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$22.2M
4
Federated Hermes
Federated Hermes
Pennsylvania
+$19.5M
5
Wells Fargo
Wells Fargo
California
+$19.2M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$13.4M
2
Millennium Management
Millennium Management
New York
-$8.67M
3
PC
Pier Capital
Connecticut
-$4.94M
4
BBA
Baker Bros. Advisors
New York
-$3.91M
5
VM
VHCP Management
New York
-$3.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
ARTA
26
A.R.T. Advisors
New York
$1.87M +$1.88M +31,548 New
NFA
27
Nationwide Fund Advisors
Ohio
$1.6M +$1.6M +26,900 New
GTC
28
Ghost Tree Capital
New York
$1.48M +$1.49M +25,000 New
IHM
29
Iguana Healthcare Management
New York
$1.48M +$1.49M +25,000 New
TI
30
Turner Investments
Pennsylvania
$1.45M +$1.46M +24,470 New
MOACM
31
Mutual of America Capital Management
New York
$1.32M +$1.32M +22,200 New
CS
32
Credit Suisse
Switzerland
$1.12M +$1.12M +18,801 New
RSCM
33
Rock Springs Capital Management
Maryland
$1.05M +$1.06M +17,750 New
CCI
34
Columbus Circle Investors
$995K +$997K +16,761 New
Deutsche Bank
35
Deutsche Bank
Germany
$931K +$934K +15,700 New
UM
36
Ulysses Management
New York
$576K +$577K +9,700 New
SG Americas Securities
37
SG Americas Securities
New York
$410K +$410K +6,900 New
Bank of America
38
Bank of America
North Carolina
$397K +$398K +6,692 New
TD Asset Management
39
TD Asset Management
Ontario, Canada
$392K +$393K +6,600 New
U
40
UBS
Switzerland
$385K +$385K +6,479 New
Jane Street
41
Jane Street
New York
$346K -$399K -6,710 -52%
Commonwealth Equity Services
42
Commonwealth Equity Services
Massachusetts
$335K +$336K +5,645 New
Millennium Management
43
Millennium Management
New York
$302K -$8.67M -145,803 -97%
BACM
44
Blue Arrow Capital Management
New York
$297K +$297K +5,000 New
SGH
45
Schonfeld Group Holdings
New York
$264K +$265K +4,454 New
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$244K +$225K +3,775 +1,110%
Group One Trading
47
Group One Trading
Illinois
$158K +$159K +2,665 New
Goldman Sachs
48
Goldman Sachs
New York
$132K +$132K +2,219 New
Citigroup
49
Citigroup
New York
$75K +$73.8K +1,241 +6,894%
Creative Planning
50
Creative Planning
Kansas
$42K +$41.6K +700 New
1
2
3

GWPH Hedge Fund Activity: Q1 2014 in Review

68 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q1 2014, worth a combined $446M — up 175% from $162M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new GWPH positions and 7 closed out — a net gain of 42 holders — while 8 added to existing stakes and 7 trimmed.

The largest buyer was Capital Research Global Investors, opening a new position worth an estimated $48.1M. The largest seller was OrbiMed, cutting an estimated $13.4M.

  • 68 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q1 2014, up from 26 in Q4 2013.
  • Funds reported $446M of GW Pharmaceuticals Plc American Depositary Shares stock for Q1 2014, up 175% quarter-over-quarter.
  • 49 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q1 2014 and 7 closed out, a net change of +42 holders.
  • The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q1 2014 was Capital Research Global Investors, an estimated $48.1M added.
  • The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q1 2014 was OrbiMed, an estimated $13.4M sold.

Based on aggregated 13F filings for Q1 2014.